ESIS Research Group in collaboration with other international research groups have taken out a PATENT in Germany for "Composition, useful e.g. for the chemosensibilizing and simultaneous apoptosis induction of multidrug resistance of tumor cells and bacteria, comprises substituted disiloxane compound in combination with benzoxazole derivatives".
ESIS Research Group with Patent on Newspapers
